Feng, Xiaoshuang
Song, Mingyang
Preston, Mark A.
Ma, Wenjie
Hu, Yang
Pernar, Claire H.
Stopsack, Konrad H.
Ebot, Ericka M.
Fu, Benjamin C.
Zhang, Yiwen
Li, Ni
Dai, Min
Liu, Lydia
Giovannucci, Edward L.
Mucci, Lorelei A.
Funding for this research was provided by:
China Scholarship Council (201806210455)
American Cancer Society (MRSG-17-220-01-NEC)
Foundation for the National Institutes of Health (R00 CA215314, R03CA226942)
Dana-Farber/Harvard Cancer Center (P30 CA 06516)
Article History
Received: 15 October 2019
Revised: 23 April 2020
Accepted: 6 May 2020
First Online: 29 May 2020
Ethics approval and consent to participate
: The study protocol was approved by the institutional review boards of the Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required.
: The datasets generated during and/or analysed during the current study are not publicly available due to confidentiality reasons, but anonymised versions may be available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This work was supported by the National Institutes of Health (T32 CA09001 to C.H.P.; R03CA226942 to E.L.G; R00 CA215314 to M.S.) and American Cancer Society (MRSG-17-220-01-NEC to M.S.). The Health Professionals Follow-up Study is supported by U01 CA 167552 from the National Cancer Institute. The TMAs were constructed by the Tissue Microarray Core Facility at the Dana-Farber/Harvard Cancer Center (P30 CA 06516). X.F. was supported by the program of China Scholarships Council (No.201806210455).